Commonwealth Equity Services
KRYS icon

Commonwealth Equity Services’s Krystal Biotech KRYS Stock Holding History

Commonwealth Equity Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.78M Sell
11,357
-759
-6% -$263K ﹤0.01% 1559
2026
Q2 		$4.5M Buy
12,116
+525
+5% +$157K 0.01% 1483
2026
Q1 		$2.99M Buy
11,591
+1,704
+17% +$453K ﹤0.01% 1699
2025
Q4 		$2.44M Sell
9,887
-119
-1% -$25K ﹤0.01% 1828
2025
Q3 		$1.77M Buy
10,006
+1,791
+22% +$268K ﹤0.01% 2100
2025
Q2 		$1.13M Buy
8,215
+912
+12% +$134K ﹤0.01% 2462
2025
Q1 		$1.32M Buy
7,303
+2,437
+50% +$410K ﹤0.01% 2247
2024
Q4 		$762K Buy
4,866
+190
+4% +$33.7K ﹤0.01% 2615
2024
Q3 		$851K Buy
4,676
+52
+1% +$10K ﹤0.01% 2478
2024
Q2 		$849K Buy
4,624
+41
+0.9% +$6.88K ﹤0.01% 2404
2024
Q1 		$815K Sell
4,583
-1
-0% -$139 ﹤0.01% 2400
2023
Q4 		$569K Buy
4,584
+158
+4% +$17.5K ﹤0.01% 2589
2023
Q3 		$513K Buy
4,426
+110
+3% +$13.4K ﹤0.01% 2564
2023
Q2 		$507K Hold
4,316
– – ﹤0.01% 2614
2023
Q1 		$345K Hold
4,316
– – ﹤0.01% 2840
2022
Q4 		$341K Sell
4,316
-5
-0.1% -$371 ﹤0.01% 2772
2022
Q3 		$301K Buy
4,321
+31
+0.7% +$2.24K ﹤0.01% 2826
2022
Q2 		$281K Buy
4,290
+772
+22% +$48K ﹤0.01% 2889
2022
Q1 		$234K Buy
+3,518
New +$220K ﹤0.01% 3183

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Commonwealth Equity Services's KRYS Position: Q3 2026 in Review

Commonwealth Equity Services reduced its Krystal Biotech (KRYS) stake by 6.3% in Q3 2026, selling an estimated $263K and leaving 11,357 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Commonwealth Equity Services first reported a position in KRYS in Q1 2022 and has held it in 19 quarters since. The position peaked at $4.5M in Q2 2026. 264 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Commonwealth Equity Services held 11,357 shares of Krystal Biotech worth $3.78M as of Q3 2026.
  • Commonwealth Equity Services sold 759 Krystal Biotech shares in Q3 2026, an estimated $263K.
  • Krystal Biotech made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #1559 holding.
  • Commonwealth Equity Services first reported a position in Krystal Biotech in Q1 2022 and has held it in 19 quarters since.
  • Commonwealth Equity Services's Krystal Biotech position peaked at $4.5M in Q2 2026.
  • 264 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.